[West Nile virus (WNV): generalities and implications for blood transfusion]

Transfus Clin Biol. 2005 Feb;12(1):11-7. doi: 10.1016/j.tracli.2005.01.004.
[Article in French]

Abstract

West Nile virus (WNV) is an arbovirus (genus Flavivirus, Family Flaviviridae, transmitted to humans by mosquito bite. In most cases (80%), human infection remains asymptomatic. Severe central nervous system complications (encephalitis and meningoencephalitis) are rare. In the Old World, the virus circulation has been demonstrated in Asia, Australia, Africa, Middle East and Europe. Several outbreaks in humans have been described. Following its introduction into North America in 1999, WN virus has been responsible of a large number of human cases in USA and Canada. For the first time, viral transmission by blood products was clearly demonstrated in USA in 2002. In France, the presence of virus has been reported in the Southeastern departments since 1962. In 2003, the occurrence of humans cases at specific geographical foci urged the French National Blood Agency (etablissement francais du sang) to take preventive measures for evaluating the virus transmission risks.

Publication types

  • Review

MeSH terms

  • Animals
  • Bird Diseases / virology
  • Birds / virology
  • Blood Donors
  • Blood Transfusion / standards
  • Culicidae / virology
  • Disease Reservoirs
  • Donor Selection / standards
  • Europe / epidemiology
  • France / epidemiology
  • Humans
  • Insect Bites and Stings / virology
  • Insect Vectors / virology
  • North America / epidemiology
  • Transfusion Reaction*
  • Viremia / transmission*
  • Viremia / virology
  • West Nile Fever* / diagnosis
  • West Nile Fever* / epidemiology
  • West Nile Fever* / prevention & control
  • West Nile Fever* / transmission
  • West Nile Fever* / veterinary
  • West Nile virus / physiology